CA1027929A - 7-alkyl-.delta.3,5-steroids - Google Patents

7-alkyl-.delta.3,5-steroids

Info

Publication number
CA1027929A
CA1027929A CA192,667A CA192667A CA1027929A CA 1027929 A CA1027929 A CA 1027929A CA 192667 A CA192667 A CA 192667A CA 1027929 A CA1027929 A CA 1027929A
Authority
CA
Canada
Prior art keywords
steroids
delta
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA192,667A
Other languages
French (fr)
Inventor
Joyce F. Grunwell
John O. Johnston
Vladimir Petrow
Philip M. Weintraub
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Ltd Canada
Original Assignee
Richardson Merrell Canada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Canada Ltd filed Critical Richardson Merrell Canada Ltd
Application granted granted Critical
Publication of CA1027929A publication Critical patent/CA1027929A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0029—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CA192,667A 1973-03-26 1974-02-15 7-alkyl-.delta.3,5-steroids Expired CA1027929A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US344838A US3890356A (en) 1973-03-26 1973-03-26 7-Alkyl-{66 {hu 3,5{b -steroids

Publications (1)

Publication Number Publication Date
CA1027929A true CA1027929A (en) 1978-03-14

Family

ID=23352273

Family Applications (1)

Application Number Title Priority Date Filing Date
CA192,667A Expired CA1027929A (en) 1973-03-26 1974-02-15 7-alkyl-.delta.3,5-steroids

Country Status (9)

Country Link
US (1) US3890356A (en)
JP (1) JPS49126661A (en)
AU (1) AU6558474A (en)
BE (1) BE812836A (en)
CA (1) CA1027929A (en)
DE (1) DE2413559A1 (en)
FR (1) FR2223014A1 (en)
GB (1) GB1410294A (en)
ZA (1) ZA74932B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
MX9301121A (en) 1992-03-02 1993-09-01 Schering Ag METHOD AND EQUIPMENT FOR ORAL CONTRACEPTION AND REGULATION OF MENSTRUATION WITH ESTROGEN / PROGESTIN / ANIPROGESTIN.
US7704983B1 (en) 1992-03-02 2010-04-27 Eastern Virginia Medical School Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
US5516769A (en) * 1993-02-19 1996-05-14 The Medical College Of Hampton Roads Method of inhibiting fertilization
US5468736A (en) * 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy
DE4344463A1 (en) * 1993-12-22 1995-06-29 Schering Ag Combination product for contraception

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3351639A (en) * 1963-03-20 1967-11-07 American Cyanamid Co 17-alkyl-20-keto substituted pregnenes, pregnadienes and methods of preparing the same
US3246022A (en) * 1964-06-04 1966-04-12 Searle & Co 3-aryl-17beta-oxy (androsta/estra)-3, 5-dienes
US3471531A (en) * 1966-04-07 1969-10-07 Herchel Smith Synthesis of gona-3,5-dienes
CH537373A (en) * 1966-10-28 1973-05-31 Ciba Geigy Ag Delta3 5-7alpha-methyloestradienes having oestrogenic
US3553213A (en) * 1969-03-17 1971-01-05 American Home Prod 17-alpha-aminoalkynyl-3-chloro 19-norsteroidal 3,5-dienes

Also Published As

Publication number Publication date
FR2223014A1 (en) 1974-10-25
ZA74932B (en) 1975-01-29
JPS49126661A (en) 1974-12-04
BE812836A (en) 1974-07-15
DE2413559A1 (en) 1974-10-17
AU6558474A (en) 1975-08-14
GB1410294A (en) 1975-10-15
US3890356A (en) 1975-06-17

Similar Documents

Publication Publication Date Title
IE39302L (en) 1,4- diazacycloheptanes.
CA1008860A (en) 1-phenyl-substituted 1,3,5-triazines
CA1023746A (en) 2,6-dimethyl-4-phenyl-1,4-dihydropyridines
CA1030951A (en) 1,3-OXYGENATED 8.alpha.-OESTRATRIENES
CA1030950A (en) 1,3-OXYGENATED 8.alpha.-OESTRATRIENES
CA1026760A (en) 3,4-dihydro-2h-naphthalin-1-one-5-oxypropyl-piperazine derivatives
CA1027929A (en) 7-alkyl-.delta.3,5-steroids
CA1033716A (en) 17.beta.-HYDROXY-16,16-DIMETHYLESTR-4-EN-3-ONE
CA1008072A (en) Amino substituted 1,2,4-triazinones
CA1029726A (en) 1,8-naphthyridine-3-carboxamidetetrazolyl derivatives
CA1018967A (en) 15.alpha., 16.alpha.-METHYLENE-.DELTA.4-PREGNENES
CA1024140A (en) 6-anilino-1,4,5-trihydroxyanthraquinones
AU503626B2 (en) Substituted 1, 5-diphenyl-3-formazancarbonitriles
CA1031335A (en) 6,7,8,9-tetrahydro-1h-pyrazolo (3,4-b) (1,5) diazocines
CA1018157A (en) 8,8'-dioxo-6,6'-azopurine
CA1031779A (en) 1,3,4-thiadiazol-2-yl-ureas with selective-herbicidal action
CA1021331A (en) 9,12-bridged ethenoanthracenes and compounds derived therefrom
AU478074B2 (en) 1,3-oxygenated s-oestratrienes
CA1032163A (en) 1,2-dihydrophthalazine-1-acetic acids
AU489033B2 (en) HERDICIDAL l, 3, 4-THIADIAZOL-2-YL-UREAS
AU7206674A (en) 2, 2-disubstitute-benzodioxoles
CA883816A (en) 2-chloro-.delta.1,4-steroids
CA882106A (en) 4,6-dichloro-.delta.4,6-oestradienes
CA1010861A (en) 9.beta.-HYDROXY-5-METHYL-6,7-BENZOMORPHANS
AU487239B2 (en) 2, 3-methanoprostaglandin derivatives